Clinical Trial Update: Efficacy of Atomoxetine for ADHD in Adolescents and Young Adults With SUD [Phase 4]

View source ↗

Summary

This Phase 4 study evaluating atomoxetine for ADHD in adolescents and young adults with substance use disorder has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Substance Use Disorder

Drugs mentioned

• STRATTERA (Atomoxetine hydrochloride)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Attention Deficit Hyperactivity Disorder, Substance Use Disorder | Phase 4 | Status: WITHDRAWN